In line with this, rapamycin was found to suppress cancers and extend life in a range of genetic early-onset cancer models, such as p53 mutant mice, Apc mutant animals, Rb mutant mice and HER-2/neu transgenic mice [55–58], strongly implicating direct anti-cancer action in the longevity effects seen in these studies. Here, ERBB2 is linked to cancer.